Archives

Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

B – Proven Leader in Neurology Drug Development, Including for Several Approved Multiple Sclerosis Therapies – – Strong Experience in Advancing Late-Stage Clinical Programs and… Login to continue reading Login…

Read MoreImmunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026

B Presentations to highlight hypothermic oxygenated perfusion (HOPE) with VitaSmart™ in liver transplants, including pediatric patients and partial grafts DULUTH, Ga., April 28, 2026 /PRNewswire/… Login to continue reading Login…

Read MoreBridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May 6-9, 2026

HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy

B Industry veteran brings 25+ years of global clinical leadership from Ferring, Novartis, NIBR, Bayer, and SixPeaks Bio to support HERVolution’s cardiometabolic pipeline Tankó’s strategic… Login to continue reading Login…

Read MoreHERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy